학술논문

Loss of CD40 attenuates experimental diabetes-induced retinal inflammation but does not protect mice from electroretinogram defects
Document Type
article
Source
Subject
Biomedical and Clinical Sciences
Ophthalmology and Optometry
Prevention
Eye Disease and Disorders of Vision
Diabetes
Neurosciences
Aetiology
2.1 Biological and endogenous factors
Metabolic and endocrine
Eye
Animals
CD40 Antigens
Diabetes Mellitus
Experimental
Diabetic Retinopathy
Electroretinography
Female
Intercellular Adhesion Molecule-1
Interleukin-1beta
Male
Mice
Mice
Inbred C57BL
Mice
Knockout
Nitric Oxide Synthase Type II
RNA
Messenger
Real-Time Polymerase Chain Reaction
Retina
Retinitis
Tumor Necrosis Factor-alpha
Up-Regulation
CD40
Diabetic retinopathy
Electroretinogram
Inflammation
Medical and Health Sciences
Psychology and Cognitive Sciences
Neurology & Neurosurgery
Ophthalmology and optometry
Language
Abstract
Chronic low grade inflammation is considered to contribute to the development of experimental diabetic retinopathy (DR). We recently demonstrated that lack of CD40 in mice ameliorates the upregulation of inflammatory molecules in the diabetic retina and prevented capillary degeneration, a hallmark of experimental diabetic retinopathy. Herein, we investigated the contribution of CD40 to diabetes-induced reductions in retinal function via the electroretinogram (ERG) to determine if inflammation plays a role in the development of ERG defects associated with diabetes. We demonstrate that diabetic CD40-/- mice are not protected from reduction to the ERG b-wave despite failing to upregulate inflammatory molecules in the retina. Our data therefore supports the hypothesis that retinal dysfunction found in diabetics occurs independent of the induction of inflammatory processes.